Europe – MDCG 2024-16: Manufacturer Information Form on Interruption or Discontinuation of Supply of...

The Medical Device Coordination Group (MDCG) has introduced new guidance under MDCG 2024-16, streamlining how manufacturers report interruptions or discontinuations in the supply of...

USA – FDA final guidance adds more details to Q-Sub program

The US Food and Drug Administration has finalized an updated guidance on its Q-Submissions program that allows medtech companies to engage with regulators early...
ISO 14971 :2019 - GAP-ANALYSIS résumé versus l’ancienne version ISO EN FR 14971 : 2013.

USA – Medical Devices Regulatory Update / FDIS 10993-1 Released: Requirements and General Principles...

The Final Draft International Standard (FDIS) of ISO 10993-1 has been released launching the 8-week ballot period and signaling important changes ahead for medical...

USA – FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease

The U.S. Food and Drug Administration today cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s...

USA – Drug, device makers scramble for tariff exemptions, warn of supply disruptions

Drug and device manufacturers are raising concerns about President Donald Trump’s tariffs on imports from China, Mexico, and Canada, warning that they could worsen...

USA – FDA issues much-anticipated guidance on pulse oximeters

The Food and Drug Administration on Monday released much-anticipated testing recommendations for pulse oximeters. The draft guidance follows years of discussion about concerns that the devices can be...

USA – FDA issues draft guidance on developing and managing AI-enabled devices

The US Food and Drug Administration (FDA) on Monday published a much-anticipated guidance on developing and managing medical devices with artificial intelligence (AI). The...

USA – FDA updates GUDID final guidance

The US Food and Drug Administration (FDA) issued an updated final guidance on Tuesday addressing the submission of unique device identifiers (UDIs) to the...
Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Guidance on terms and conditions for class II to IV medical devices

The Food and Drugs Act (FDA) and its regulations give Health Canada the authority to regulate food, drugs (including natural health products), medical devices and cosmetics....
Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Drug and medical device databases

This list of Health Canada's drug and medical device databases briefly describes the information available in each database. It does not provide an in...

NOS PROCHAINES FORMATIONS